Anlon Healthcare Limited IPO
MainboardOffer Date: Aug 26, 2025 - Aug 29, 2025
₹ 14924 /164 Shares
26 Aug, 2025
Open Date29 Aug, 2025
Close Date01 Sep, 2025
Allotment Date03 Sep, 2025
Listing DateIssue Price
₹86-91 per equity shareFace Value
₹10 Per Equity ShareListing at Group
BSE, NSERegistrar
Kfin Technologies LtdMarket Lot
164 Shares (₹14,924/-)Lead Manager
Interactive Financial Services LtdIssue Size
1,33,00,000 shares(aggregating up to ₹121.03 Cr)Retail Portion
10% (Number of Retail Applications: 8,110 Approx),(Number of S-HNI Applications : 290 Approx),
(Number of B-HNI Applications : 579 Approx)
Subscription
N/A timesIPO Docs
DRHPAnlon Healthcare IPO Details
Anlon Healthcare IPO is a book-built issue of ₹121.03 crores, The total issue size is ₹121.03 crores. The IPO of Anlon Healthcare is priced at ₹86-91 per equity share, which has a face value of ₹10 Per Equity Share each, IPO bidding starts from Aug 26, 2025 and ends on Aug 29, 2025. The allotment for Anlon Healthcare IPO will be finalized on Sep 1, 2025. Anlon Healthcare IPO will be listed on BSE, NSE, with a tentative listing date fixed as Sep 3, 2025. The company shall list its equity shares on the BSE, NSE. Kfin Technologies Ltd is the registrar of the issue.
Retail investors can bid for a minimum of 164 shares, extendable to 14,924. S-HNIs will be able to bid for 2,296 shares at ₹2,08,936, while B-HNIs can also apply for a bid of 11,152 shares at ₹10,14,832. The book-running lead manager for the IPO is/are Interactive Financial Services Ltd.
The total issue ₹121.03 crore, comprising a fresh issue of 1,33,00,000 shares ₹121.03 crore and
The Anlon Healthcare IPO sets its price band at 86-91 for each share. A single application for Anlon Healthcare Limited IPO must contain at least 164 shares. Sentiment investors need to invest a minimum of 164 through their retail account. For investors to prevent oversubscription issues, they should submit bids at the cutoff price, which estimates about ₹14,924 In order to participate in the sNII, investors must purchase at least 14 lots of 2,296 shares for ₹2,08,936, while the bNII requires 68 lots of 11,152 shares for an investment of ₹10,14,832.
Anlon Healthcare Valuations
EPS Pre IPO
₹/-EPS Post IPO
₹/-P/E Pre IPO
P/E Post IPO
ROE
%ROCE
%Debt/Equity
RoNW
%PAT Margin
Price to Book Value
Anlon Healthcare Company Financials All values are in ₹ Cr.
| 31-Mar-24 | 31-Mar-23 | 31-Mar-22 | |
|---|---|---|---|
| Assets | 128.0 | 111.55 | N/A |
| Revenue | 66.69 | 113.12 | N/A |
| Profit After Tax | 9.66 | 5.82 | N/A |
| Net Worth | 21.03 | 7.37 | N/A |
| Reserves & Surplus | 5.03 | -4.63 | N/A |
| Total Borrowing | 74.56 | 66.39 | N/A |
About The Company
Anlon Healthcare Limited was incorporated in 2013. It is a chemical manufacturing firm involved in the production of Pharma Intermediates and active pharmaceutical ingredients (APIs).
The firm produces high-purity pharmaceutical intermediates (for API synthesis) and active pharmaceutical ingredients (utilized in formulations for pharmaceuticals, nutraceuticals, personal care, and animal health products).The firm deals in pharma intermediates, APIs for drugs, nutraceuticals, personal care, and veterinary products, all of which are produced to Indian and international pharmacopeia standards such as IP, BP, EP, JP, and USP.Besides producing Pharma Intermediates and APIs to international specifications, the firm now provides contract manufacturing of complex chemicals beyond purity levels and lowering impurities to suit particular customers' requirements.
The firm has been approved by ANVISA, NMPA, and PMDA for loxoprofen sodium dihydrate and loxoprofen acid APIs in terms of Drug Master File (DMF). The firm has submitted 21 DMFs to worldwide authorities and is submitting for Ketoprofen and Dexketoprofen Trometamol approvals.65 commercial products, 28 pilot-scale products, and 49 lab-scale products are part of the firm's portfolio.
The firm maintains product quality through thorough testing, analysis, and process optimization. Backed by four laboratories, the 34-strong team, which comprises 24 science graduates, guarantees that products meet customer and industry requirements.
Anlon Healthcare - Promoter(s)
Pre Issue Share Holding: N/A%
Post Issue Share Holding: N/A%
- Punitkumar R. rasadia
- Meet Atulkumar Vachhani
- Mamata punitkumar Rasadia
Anlon Healthcare IPO - Issue Objectives
- Funding capital expenditure requirements for Proposed Expansion
- Full or part repayment and/or prepayment of certain outstanding secured borrowingssecured borrowing (term loan)availed by the Company
- Funding the working capital requirements of the Company
- General corporate purposes
Other Details
Anlon Healthcare
101/102, Silvercoin Complex, Opp.Crystal Mall,Kalawad Road Rajkot, Gujarat, 360005Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: ahl.ipo@kfintech.com
Anlon Healthcare IPO - FAQs
Ans. Anlon Healthcare Limited IPO is a Mainboard IPO. The issue is priced at ₹86-91 per equity share. The minimum order quantity is 164 Shares. The IPO opens on Aug 26, 2025, and closes on Aug 29, 2025. Kfin Technologies Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Ans. The Anlon Healthcare Limited IPO opens on Aug 26, 2025 and closes on Aug 29, 2025.
Ans. The size of Anlon Healthcare Limited IPO is 1,33,00,000 shares(aggregating up to ₹121.03 Cr).
Ans. The IPO price band is set between ₹86-91 per equity share.
Ans. To apply for Anlon Healthcare Limited IPO IPO, follow the steps given below:
- - Open the IPO Ji App or Website
- - Find Anlon Healthcare Limited IPO in the List of IPOs
- - Press "Apply" Button
- - Select Your Demat Account
- - Select Your Shares Quantity and Submit
- - Track Your IPO Status
Ans. The share allotment date of Anlon Healthcare Limited IPO is Sep 1, 2025.
Ans. The Anlon Healthcare Limited IPO will be listed on Sep 3, 2025.
Ans. Follow the steps to check the allotment status for Anlon Healthcare Limited IPO here.
